SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RT who wrote (3851)9/24/1997 11:40:00 AM
From: Navigator One   of 3991
 
To all:

JOHKGUN reported, September 17th on the Motley Fool thread, the following history of Vinik's earlier holdings.

MU from $35 to $90
CREAF from $6 to $7 to $22
INVX from $12 to $33

"The above action all happen (sic) within 12 months!"

I do not know if these figures are accurate. Under the assumption that they are, Vinik realized the following, relatively tight, multiples on his original investments:

MU x 2.57
CREAF x 3.14
INVX x 2.75

Applying these multiples to his approximate average cost of $29 for VVUS he might be ready to move on when price hits between $74.53 to $91.06.

Not an overly valuable analysis but gives is a peek into where Vinik has left the table in the past.

Navigator One
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News